实验室资讯学的全球市场：市场规模和占有率分析（依产品、交付模式和组件）、工业需求预测（截至 2030 年）

2023年全球实验室资讯学市场价值为43.762亿美元，2024-2030年复合年增长率为11.4%，到2030年达到91.766亿美元。产业成长很大程度上与实验室自动化需求的快速成长以及生物样本库/生物样本库以及生物技术和製药产业研发支出的增加有关。

基于云端的品类引领市场

从交付方式来看，到 2023 年，基于云端的类别将占据最大占有率，达到 55%，而这一趋势预计将持续下去。

北美是最赚钱的

从地区来看，北美将在 2023 年以 40% 左右的占有率引领该行业，并预计到本十年末将实现强劲增长。最先进的 IT 基础设施、高数位素养以及支援实验室资讯系统接受的立法是产业成长的关键驱动力。

此外，不断上涨的医疗保健成本和控製成本的需要促使整个行业使用 LIMS。此外，成熟製药公司的存在以及控制与资讯管理和分析相关的营运成本的日益增长的需求是行业扩张的主要驱动力。

在本报告中，我们分析了全球实验室资讯学市场，包括市场的基本结构、最新情况、主要促进和抑制因素以及全球、依地区和主要国家的市场规模前景（数量/价值）基础，2017年-2030年），依产品、交付模式、零件和行业划分的详细趋势、当前市场竞争状况以及主要公司简介。

目录

第一章 调查范围

第二章研究方法

第3章执行摘要

第四章 市场指标

第五章 产业展望

• 市场动态
  • 趋势
  • 促进因素
  • 抑制因素/课题
  • 促进/抑制因素影响分析
• 新型冠状病毒感染（COVID-19）的影响
• 波特五力分析

第六章 世界市场

• 概述
• 市场收入：依产品分类（2017-2030）
• 市场收入：依交付模式分类（2017-2030）
• 市场收入：依组成部分（2017-2030）
• 市场收入：依行业分类（2017-2030）
• 市场收入：依地区（2017-2030）

第七章 北美市场

• 概述
• 市场收入：依产品分类（2017-2030）
• 市场收入：依交付模式分类（2017-2030）
• 市场收入：依组成部分（2017-2030）
• 市场收入：依行业分类（2017-2030）
• 市场收入：依国家分类（2017-2030）

第八章欧洲市场

第九章亚太市场

第十章 拉丁美洲市场

第十一章 中东和非洲（MEA）市场

第十二章 美国市场

• 概述
• 市场收入：依产品分类（2017-2030）
• 市场收入：依交付模式分类（2017-2030）
• 市场收入：依组成部分（2017-2030）
• 市场收入：依行业分类（2017-2030）

第十三章 加拿大市场

第十四章 德国市场

第十五章 法国市场

第十六章 英国市场

第十七章 义大利市场

第十八章 西班牙市场

第十九章 日本市场

第20章 中国市场

第21章 印度市场

第22章澳洲市场

第23章 韩国市场

第24章 巴西市场

第25章 墨西哥市场

第26章 沙乌地阿拉伯市场

第27章南非市场

第28章 阿拉伯联合大公国（UAE）市场

第29章竞争格局

• 市场参与者及其提供的产品/服务的列表
• 主要企业竞争基准
• 主要公司的产品基准
• 近期策略发展状况

第三十章 公司简介

• LabVantage Solutions Inc.
• Thermo Fisher Scientific Inc.
• STARLIMS Corporation
• PerkinElmer Inc.
• LABWORKS LLC
• Autoscribe Informatics
• Dassault Systemes SE
• Agilent Technologies Inc.
• Cerner Corporation
• McKesson Corporation

第31章附录

The laboratory informatics market had a size of USD 4,376.2 million in 2023, which will power at a compound annual growth rate of 11.4% by 2024- 2030, touching USD 9,176.6 million by 2030. The industry growth has a lot to do with the surge in the demand for lab automation, along with biobanks/biorepositories and an increase in research and development spending in the biotech and pharma sectors.

Growth Drivers

The increase in the demand for lab automation will power the acceptance of these systems. Owing to the fast enhancements in molecular genomics and genetic testing procedures, the data produced by labs has quickly increased.

Also, the requirement for automated lab systems will increase as a result of the shift in the preference in the direction of personalized care, increase in numerous cancer genomics investigations, and development in patient engagement needs.

The industry will benefit from the governing authorities' snowballing pressure for the disposition of lab automation systems.

Healthcare processes have turned out to be reproducible and repeatable with the mounting acceptance of process automation and robotics.

The growing usage of high-output technologies has made it likely to assess experimental results more competently, which advances the general efficiency of laboratory operations.

The ECM Category has the Fastest Growth

The ECM category will grow the fastest in the years to come, with a 12% rate in the industry.

The acceptance of ECM is growing as it provides comprehensive and integrated solutions for meeting the rising issues in the healthcare sector.

ECM provides a centralized method for seizing, making, organizing, accessing, and examining the whole ecosystem of knowledge assets, media, and e-documents in a company.

Moreover, companies in the industry offer more than a few services associated with ECM, such as design, consultation, installation, and upkeep of these software solutions.

Cloud-Based Category Leads the Market

On the basis of delivery mode, the cloud-based category had the largest share of 55%, in 2023, and it will continue like this in the years to come as well.

This is for the reason that cloud-deployed LIMs make available space on on-premises computer devices, by stowing vast data amounts offsite, which likewise makes it easier for retrieving it whenever the client requires it.

Cloud-based LIMs can be availed of in three ways, PaaS, IaaS, and SaaS. On the SaaS platform, IBM offers its Watson Analytics services. Additionally, LabVantage Solutions Inc. and Core Informatics provide cloud-based services for LIMS.

North America Makes the Most Revenue

North America leads the industry with about 40% share, in 2023, and it will power at a robust rate by the end of this decade. The accessibility of cutting-edge IT infra, together with high levels of digital literacy and legislation boosting the acceptance of lab information systems, is the key driver for the growth of the industry.

Furthermore, the growing healthcare expenditures and the necessity to stem this surge have brought about the usage of LIMSs across industries. Additionally, the existence of well-established pharma businesses and the mounting requirement to control operational costs associated with info management and analysis are the main drivers for the expansion of the industry.

Competitive Analysis

With an increase in the requirement for COVID-19 tests, clinical labs extended the degree of their operations. In turn, the large number of patients led to challenges in emerging, regulating, and validating novel approaches for testing patients, along with gathering, stowing, examining, and rapidly and precisely reporting massive volumes of patient test data.

LIM is important for coping with the requirement for COVID-19 tests in clinical labs, which encouraged product acceptance during the outbreak of the pandemic.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by product
  • 1.4.2. Market size breakdown, by delivery mode
  • 1.4.3. Market size breakdown, by component
  • 1.4.4. Market size breakdown, by industry
  • 1.4.5. Market size breakdown, by region
  • 1.4.6. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Revenue, by Product (2017-2030)
• 6.3. Market Revenue, by Delivery Mode (2017-2030)
• 6.4. Market Revenue, by Component (2017-2030)
• 6.5. Market Revenue, by Industry (2017-2030)
• 6.6. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Revenue, by Product (2017-2030)
• 7.3. Market Revenue, by Delivery Mode (2017-2030)
• 7.4. Market Revenue, by Component (2017-2030)
• 7.5. Market Revenue, by Industry (2017-2030)
• 7.6. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Revenue, by Product (2017-2030)
• 8.3. Market Revenue, by Delivery Mode (2017-2030)
• 8.4. Market Revenue, by Component (2017-2030)
• 8.5. Market Revenue, by Industry (2017-2030)
• 8.6. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Revenue, by Product (2017-2030)
• 9.3. Market Revenue, by Delivery Mode (2017-2030)
• 9.4. Market Revenue, by Component (2017-2030)
• 9.5. Market Revenue, by Industry (2017-2030)
• 9.6. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Revenue, by Product (2017-2030)
• 10.3. Market Revenue, by Delivery Mode (2017-2030)
• 10.4. Market Revenue, by Component (2017-2030)
• 10.5. Market Revenue, by Industry (2017-2030)
• 10.6. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Revenue, by Product (2017-2030)
• 11.3. Market Revenue, by Delivery Mode (2017-2030)
• 11.4. Market Revenue, by Component (2017-2030)
• 11.5. Market Revenue, by Industry (2017-2030)
• 11.6. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Revenue, by Product (2017-2030)
• 12.3. Market Revenue, by Delivery Mode (2017-2030)
• 12.4. Market Revenue, by Component (2017-2030)
• 12.5. Market Revenue, by Industry (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Revenue, by Product (2017-2030)
• 13.3. Market Revenue, by Delivery Mode (2017-2030)
• 13.4. Market Revenue, by Component (2017-2030)
• 13.5. Market Revenue, by Industry (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Revenue, by Product (2017-2030)
• 14.3. Market Revenue, by Delivery Mode (2017-2030)
• 14.4. Market Revenue, by Component (2017-2030)
• 14.5. Market Revenue, by Industry (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Revenue, by Product (2017-2030)
• 15.3. Market Revenue, by Delivery Mode (2017-2030)
• 15.4. Market Revenue, by Component (2017-2030)
• 15.5. Market Revenue, by Industry (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Revenue, by Product (2017-2030)
• 16.3. Market Revenue, by Delivery Mode (2017-2030)
• 16.4. Market Revenue, by Component (2017-2030)
• 16.5. Market Revenue, by Industry (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Revenue, by Product (2017-2030)
• 17.3. Market Revenue, by Delivery Mode (2017-2030)
• 17.4. Market Revenue, by Component (2017-2030)
• 17.5. Market Revenue, by Industry (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Revenue, by Product (2017-2030)
• 18.3. Market Revenue, by Delivery Mode (2017-2030)
• 18.4. Market Revenue, by Component (2017-2030)
• 18.5. Market Revenue, by Industry (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Revenue, by Product (2017-2030)
• 19.3. Market Revenue, by Delivery Mode (2017-2030)
• 19.4. Market Revenue, by Component (2017-2030)
• 19.5. Market Revenue, by Industry (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Revenue, by Product (2017-2030)
• 20.3. Market Revenue, by Delivery Mode (2017-2030)
• 20.4. Market Revenue, by Component (2017-2030)
• 20.5. Market Revenue, by Industry (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Revenue, by Product (2017-2030)
• 21.3. Market Revenue, by Delivery Mode (2017-2030)
• 21.4. Market Revenue, by Component (2017-2030)
• 21.5. Market Revenue, by Industry (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Revenue, by Product (2017-2030)
• 22.3. Market Revenue, by Delivery Mode (2017-2030)
• 22.4. Market Revenue, by Component (2017-2030)
• 22.5. Market Revenue, by Industry (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Revenue, by Product (2017-2030)
• 23.3. Market Revenue, by Delivery Mode (2017-2030)
• 23.4. Market Revenue, by Component (2017-2030)
• 23.5. Market Revenue, by Industry (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Revenue, by Product (2017-2030)
• 24.3. Market Revenue, by Delivery Mode (2017-2030)
• 24.4. Market Revenue, by Component (2017-2030)
• 24.5. Market Revenue, by Industry (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Revenue, by Product (2017-2030)
• 25.3. Market Revenue, by Delivery Mode (2017-2030)
• 25.4. Market Revenue, by Component (2017-2030)
• 25.5. Market Revenue, by Industry (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Revenue, by Product (2017-2030)
• 26.3. Market Revenue, by Delivery Mode (2017-2030)
• 26.4. Market Revenue, by Component (2017-2030)
• 26.5. Market Revenue, by Industry (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Revenue, by Product (2017-2030)
• 27.3. Market Revenue, by Delivery Mode (2017-2030)
• 27.4. Market Revenue, by Component (2017-2030)
• 27.5. Market Revenue, by Industry (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Revenue, by Product (2017-2030)
• 28.3. Market Revenue, by Delivery Mode (2017-2030)
• 28.4. Market Revenue, by Component (2017-2030)
• 28.5. Market Revenue, by Industry (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. LabVantage Solutions Inc.
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Thermo Fisher Scientific Inc.
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. STARLIMS Corporation
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. PerkinElmer Inc.
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. LABWORKS LLC
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. Autoscribe Informatics
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Dassault Systemes SE
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary
• 30.8. Agilent Technologies Inc.
  • 30.8.1. Business overview
  • 30.8.2. Product and service offerings
  • 30.8.3. Key financial summary
• 30.9. Cerner Corporation
  • 30.9.1. Business overview
  • 30.9.2. Product and service offerings
  • 30.9.3. Key financial summary
• 30.10. McKesson Corporation
  • 30.10.1. Business overview
  • 30.10.2. Product and service offerings
  • 30.10.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports